NCT03800017View on ClinicalTrials.gov

Skeletal Muscle Function in Interstitial Lung Disease

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisHypersensitivity PneumonitisSclerodermaNonspecific Interstitial Pneumonia
Interventions
BIOLOGICAL

Hyperoxia

Participants breathe 60% oxygen during exercise

Trial Locations (1)

V6Z1Y6

RECRUITING

St. Paul's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER